Insulin-Inducible SMILE inhibits hepatic gluconeogenesis

Ji Min Lee, Woo Young Seo, Hye Sook Han, Kyoung Jin Oh, Yong Soo Lee, Don Kyu Kim, Seri Choi, Byeong Hun Choi, Robert Harris, Chul Ho Lee, Seung Hoi Koo, Hueng Sik Choi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The role of a glucagon/cAMP-dependent protein kinase- inducible coactivator PGC-1α signaling pathway is well characterized in hepatic gluconeogenesis. However, an opposing protein kinase B (PKB)/Akt-inducible corepressor signaling pathway is unknown. A previous report has demonstrated that small heterodimer partner-interacting leucine zipper protein (SMILE) regulates the nuclear receptors and transcriptional factors that control hepatic gluconeogenesis. Here, we show that hepatic SMILE expression was induced by feeding in normal mice but not in db/db and high-fat diet (HFD)-fed mice. Interestingly, SMILE expression was induced by insulin in mouse primary hepatocyte and liver. Hepatic SMILE expression was not altered by refeeding in liver-specific insulin receptor knockout (LIRKO) or PKB β-deficient (PKBβ-/-) mice. At the molecular level, SMILE inhibited hepatocyte nuclear factor 4-mediated transcriptional activity via direct competition with PGC-1α. Moreover, ablation of SMILE augmented gluconeogenesis and increased blood glucose levels in mice. Conversely, overexpression of SMILE reduced hepatic gluconeogenic gene expression and ameliorated hyperglycemia and glucose intolerance in db/db and HFD-fed mice. Therefore, SMILE is an insulin-inducible corepressor that suppresses hepatic gluconeogenesis. Small molecules that enhance SMILE expression would have potential for treating hyperglycemia in diabetes.

Original languageEnglish (US)
Pages (from-to)62-73
Number of pages12
JournalDiabetes
Volume65
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Gluconeogenesis
Insulin
Liver
Co-Repressor Proteins
Proto-Oncogene Proteins c-akt
High Fat Diet
Hyperglycemia
Hepatocyte Nuclear Factor 4
Leucine Zippers
Glucose Intolerance
Insulin Receptor
Cytoplasmic and Nuclear Receptors
Cyclic AMP-Dependent Protein Kinases
Glucagon
Blood Glucose
Hepatocytes
Gene Expression

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Lee, J. M., Seo, W. Y., Han, H. S., Oh, K. J., Lee, Y. S., Kim, D. K., ... Choi, H. S. (2016). Insulin-Inducible SMILE inhibits hepatic gluconeogenesis. Diabetes, 65(1), 62-73. https://doi.org/10.2337/db15-0249

Insulin-Inducible SMILE inhibits hepatic gluconeogenesis. / Lee, Ji Min; Seo, Woo Young; Han, Hye Sook; Oh, Kyoung Jin; Lee, Yong Soo; Kim, Don Kyu; Choi, Seri; Choi, Byeong Hun; Harris, Robert; Lee, Chul Ho; Koo, Seung Hoi; Choi, Hueng Sik.

In: Diabetes, Vol. 65, No. 1, 01.01.2016, p. 62-73.

Research output: Contribution to journalArticle

Lee, JM, Seo, WY, Han, HS, Oh, KJ, Lee, YS, Kim, DK, Choi, S, Choi, BH, Harris, R, Lee, CH, Koo, SH & Choi, HS 2016, 'Insulin-Inducible SMILE inhibits hepatic gluconeogenesis', Diabetes, vol. 65, no. 1, pp. 62-73. https://doi.org/10.2337/db15-0249
Lee JM, Seo WY, Han HS, Oh KJ, Lee YS, Kim DK et al. Insulin-Inducible SMILE inhibits hepatic gluconeogenesis. Diabetes. 2016 Jan 1;65(1):62-73. https://doi.org/10.2337/db15-0249
Lee, Ji Min ; Seo, Woo Young ; Han, Hye Sook ; Oh, Kyoung Jin ; Lee, Yong Soo ; Kim, Don Kyu ; Choi, Seri ; Choi, Byeong Hun ; Harris, Robert ; Lee, Chul Ho ; Koo, Seung Hoi ; Choi, Hueng Sik. / Insulin-Inducible SMILE inhibits hepatic gluconeogenesis. In: Diabetes. 2016 ; Vol. 65, No. 1. pp. 62-73.
@article{2138a6e2d24744cba58ddc09f09faa14,
title = "Insulin-Inducible SMILE inhibits hepatic gluconeogenesis",
abstract = "The role of a glucagon/cAMP-dependent protein kinase- inducible coactivator PGC-1α signaling pathway is well characterized in hepatic gluconeogenesis. However, an opposing protein kinase B (PKB)/Akt-inducible corepressor signaling pathway is unknown. A previous report has demonstrated that small heterodimer partner-interacting leucine zipper protein (SMILE) regulates the nuclear receptors and transcriptional factors that control hepatic gluconeogenesis. Here, we show that hepatic SMILE expression was induced by feeding in normal mice but not in db/db and high-fat diet (HFD)-fed mice. Interestingly, SMILE expression was induced by insulin in mouse primary hepatocyte and liver. Hepatic SMILE expression was not altered by refeeding in liver-specific insulin receptor knockout (LIRKO) or PKB β-deficient (PKBβ-/-) mice. At the molecular level, SMILE inhibited hepatocyte nuclear factor 4-mediated transcriptional activity via direct competition with PGC-1α. Moreover, ablation of SMILE augmented gluconeogenesis and increased blood glucose levels in mice. Conversely, overexpression of SMILE reduced hepatic gluconeogenic gene expression and ameliorated hyperglycemia and glucose intolerance in db/db and HFD-fed mice. Therefore, SMILE is an insulin-inducible corepressor that suppresses hepatic gluconeogenesis. Small molecules that enhance SMILE expression would have potential for treating hyperglycemia in diabetes.",
author = "Lee, {Ji Min} and Seo, {Woo Young} and Han, {Hye Sook} and Oh, {Kyoung Jin} and Lee, {Yong Soo} and Kim, {Don Kyu} and Seri Choi and Choi, {Byeong Hun} and Robert Harris and Lee, {Chul Ho} and Koo, {Seung Hoi} and Choi, {Hueng Sik}",
year = "2016",
month = "1",
day = "1",
doi = "10.2337/db15-0249",
language = "English (US)",
volume = "65",
pages = "62--73",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "1",

}

TY - JOUR

T1 - Insulin-Inducible SMILE inhibits hepatic gluconeogenesis

AU - Lee, Ji Min

AU - Seo, Woo Young

AU - Han, Hye Sook

AU - Oh, Kyoung Jin

AU - Lee, Yong Soo

AU - Kim, Don Kyu

AU - Choi, Seri

AU - Choi, Byeong Hun

AU - Harris, Robert

AU - Lee, Chul Ho

AU - Koo, Seung Hoi

AU - Choi, Hueng Sik

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The role of a glucagon/cAMP-dependent protein kinase- inducible coactivator PGC-1α signaling pathway is well characterized in hepatic gluconeogenesis. However, an opposing protein kinase B (PKB)/Akt-inducible corepressor signaling pathway is unknown. A previous report has demonstrated that small heterodimer partner-interacting leucine zipper protein (SMILE) regulates the nuclear receptors and transcriptional factors that control hepatic gluconeogenesis. Here, we show that hepatic SMILE expression was induced by feeding in normal mice but not in db/db and high-fat diet (HFD)-fed mice. Interestingly, SMILE expression was induced by insulin in mouse primary hepatocyte and liver. Hepatic SMILE expression was not altered by refeeding in liver-specific insulin receptor knockout (LIRKO) or PKB β-deficient (PKBβ-/-) mice. At the molecular level, SMILE inhibited hepatocyte nuclear factor 4-mediated transcriptional activity via direct competition with PGC-1α. Moreover, ablation of SMILE augmented gluconeogenesis and increased blood glucose levels in mice. Conversely, overexpression of SMILE reduced hepatic gluconeogenic gene expression and ameliorated hyperglycemia and glucose intolerance in db/db and HFD-fed mice. Therefore, SMILE is an insulin-inducible corepressor that suppresses hepatic gluconeogenesis. Small molecules that enhance SMILE expression would have potential for treating hyperglycemia in diabetes.

AB - The role of a glucagon/cAMP-dependent protein kinase- inducible coactivator PGC-1α signaling pathway is well characterized in hepatic gluconeogenesis. However, an opposing protein kinase B (PKB)/Akt-inducible corepressor signaling pathway is unknown. A previous report has demonstrated that small heterodimer partner-interacting leucine zipper protein (SMILE) regulates the nuclear receptors and transcriptional factors that control hepatic gluconeogenesis. Here, we show that hepatic SMILE expression was induced by feeding in normal mice but not in db/db and high-fat diet (HFD)-fed mice. Interestingly, SMILE expression was induced by insulin in mouse primary hepatocyte and liver. Hepatic SMILE expression was not altered by refeeding in liver-specific insulin receptor knockout (LIRKO) or PKB β-deficient (PKBβ-/-) mice. At the molecular level, SMILE inhibited hepatocyte nuclear factor 4-mediated transcriptional activity via direct competition with PGC-1α. Moreover, ablation of SMILE augmented gluconeogenesis and increased blood glucose levels in mice. Conversely, overexpression of SMILE reduced hepatic gluconeogenic gene expression and ameliorated hyperglycemia and glucose intolerance in db/db and HFD-fed mice. Therefore, SMILE is an insulin-inducible corepressor that suppresses hepatic gluconeogenesis. Small molecules that enhance SMILE expression would have potential for treating hyperglycemia in diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84962159371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962159371&partnerID=8YFLogxK

U2 - 10.2337/db15-0249

DO - 10.2337/db15-0249

M3 - Article

VL - 65

SP - 62

EP - 73

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 1

ER -